Saturday, August 1, 2015

Inquirer architecture critic Inga Saffron reviews GlaxoSmithKline's new building at the Philadelphia Navy Yard

The Inquirer's architecture critic, Inga Saffron, toured and reviewed GlaxoSmithKline's new building at the Philadelphia Navy Yard.

Inquirer architecture critic Inga Saffron reviews GlaxoSmithKline's new building at the Philadelphia Navy Yard

0 comments

The Inquirer's architecture critic, Inga Saffron, toured and reviewed GlaxoSmithKline's new building at the Philadelphia Navy Yard.

A link to Inga's story in Friday's Inquirer  is here.

The drugmaker's Center City employees have moved from their previous location at Franklin Plaza to the new facility.

Saturday is the official opening. Glaxo is based in London and since no one does pomp and circumstance like the British, there will surely be some of that.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter